Organogenesis Holdings (ORGO) Non-Current Deffered Revenue (2016 - 2020)
Historic Non-Current Deffered Revenue for Organogenesis Holdings (ORGO) over the last 5 years, with Q3 2020 value amounting to $1.1 million.
- Organogenesis Holdings' Non-Current Deffered Revenue rose 4918.48% to $1.1 million in Q3 2020 from the same period last year, while for Sep 2020 it was $1.1 million, marking a year-over-year increase of 4918.48%. This contributed to the annual value of $1.0 million for FY2019, which is 67846.15% up from last year.
- Organogenesis Holdings' Non-Current Deffered Revenue amounted to $1.1 million in Q3 2020, which was up 4918.48% from $1.1 million recorded in Q2 2020.
- Organogenesis Holdings' Non-Current Deffered Revenue's 5-year high stood at $10.8 million during Q4 2016, with a 5-year trough of $74000.0 in Q4 2017.
- For the 5-year period, Organogenesis Holdings' Non-Current Deffered Revenue averaged around $4.8 million, with its median value being $1.1 million (2020).
- In the last 5 years, Organogenesis Holdings' Non-Current Deffered Revenue plummeted by 9931.8% in 2017 and then soared by 67846.15% in 2019.
- Organogenesis Holdings' Non-Current Deffered Revenue (Quarter) stood at $10.8 million in 2016, then plummeted by 99.32% to $74000.0 in 2017, then surged by 75.68% to $130000.0 in 2018, then soared by 678.46% to $1.0 million in 2019, then grew by 8.5% to $1.1 million in 2020.
- Its Non-Current Deffered Revenue was $1.1 million in Q3 2020, compared to $1.1 million in Q2 2020 and $1.1 million in Q1 2020.